Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancer

4 Jul 2018

Abstract excerpt

OBJECTIVE: To screen the methylated genes for early diagnosis and biochemical recurrence (BCR) prediction in prostate cancer (PCa) patients. METHODS: Differentially methylated CpG sites (DMCs) of PCa were screened out from The Cancer Genome Atlas (TCGA) and the Gene Expression Omnibus (GEO) database. Combined with TCGA RNA sequencing data and clinical information, the DMCs associated genes with different...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Ferroptosis and cancer prognosis
Share to Prostate Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29966681
DOI: 10.1016/j.gene.2018.06.104

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ZNF154 is a promising diagnosis biomarker and predicts biochemical recurrence in prostate cancerPMID 29966681Read ↗

Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate CancerSemantic proximity Read ↗

Comprehensive multi-omics analysis reveals the molecular mechanism of prostate cancer recurrenceSemantic proximity Read ↗

Identification of Methylation Biomarkers for Early Detection of Prostate CancerSemantic proximity Read ↗

TOP2A and PPARGC1A differentiate chromatin regulator-related subtypes for prostate cancer patients undergoing radical prostatectomySemantic proximity Read ↗

Prediction of Prognosis in Patients with Prostate Cancer by DNA Methylation ClassificationSemantic proximity Read ↗

PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profilesSemantic proximity Read ↗

Global Methylation Profiling for Risk Prediction of Prostate CancerSemantic proximity Read ↗

Development of a biochemical recurrence prediction model based on pyroptosis related genes in prostate cancerSemantic proximity Read ↗

Bioinformatic determination of the expression and clinical value of the histone lysine demethylase family in prostate cancerSemantic proximity Read ↗

Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate CancerSemantic proximity Read ↗

An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk.Semantic proximity Read ↗

Biomarker potential of ST 6 GALNAC 3 and ZNF 660 promoter hypermethylation in prostate cancer tissue and liquid biopsiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.